Ebit Zmiana Data
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Amgen USD 4.68B 65M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Bayer EUR 129M 626M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Cytokinetics USD -167.09M 12.08M 2026-09
Eisai JPY 16.7B 8.03B 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Exelixis USD 268.42M 20.01M 2026-09
Genmab DKK 407M 221M 2026-06
Glaxosmithkline GBP 2.15B 157M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
MacroGenics USD -65.25M 33.36M 2026-06
Merck USD 7.33B 6.49B 2026-09
Moderna USD 130M 945M 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novartis USD 5.14B 411M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sanofi EUR 1.12B 1.06B 2026-06
Takeda JPY 205.32B 3.9B 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Xencor USD -36.6M 41.26M 2026-06